There were 184 who had GN and PTI (of whom 31.0% had FSGS, 13.6% had IgA, 18.0% had LN, 17.4% had ANCA vasculitis, 7.6% had membranous, and 12.5% had another type of GN), and 579 controls (see Fig 1). This evidence concerns the gene CD79A and ganglioneuroma.